seen from Malaysia
seen from China
seen from Brazil
seen from China
seen from Malaysia
seen from Kazakhstan
seen from Norway
seen from United States
seen from Türkiye
seen from Malaysia
seen from China
seen from Netherlands
seen from United States
seen from Norway
seen from United States
seen from United States
seen from United States
seen from United States
seen from China
seen from United States
IDXG Stock
Interpace Biosciences, Incorporation is focused on helping healthcare providers in the diagnosis, triage, and treatment of patients through advanced diagnostics. Interpace's subsidiary. Besides holding the IDXG Stock, this company develops and commercializes molecular diagnostic tests that give top-notch genetic and mutational analysis.
EARNING UPDATE $IDXG Interpace Diagnostics Group, Inc. for quarter ending q_Jun18 - Revenue grew, Margins expanded
EARNING UPDATE $IDXG Interpace Diagnostics Group, Inc. for quarter ending q_Jun18 – Revenue grew, Margins expanded
[s2If !current_user_can(access_s2member_level0)]Please login to read the earning update on IDXG [lwa][/s2If][s2If current_user_can(access_s2member_level0)]Interpace Diagnostics Group, Inc. reported earnings (EPS) of -0.07 per share for the quarter ending q_Jun18. This is vis-vis -0.11 per share for the previous quarter ending q_Mar18, a growth of 36.4 %. Compared to last year same quarter…
View On WordPress
$IDXG 2018-08-09 : Transcripts- Edited Transcript of IDXG earnings conference call
$IDXG 2018-08-09 : Transcripts- Edited Transcript of IDXG earnings conference call
[s2If !current_user_can(access_s2member_level0)] Please login to read the transcript. [lwa] [/s2If][s2If current_user_can(access_s2member_level0)]”
Q2 2018 Interpace Diagnostics Group Inc Earnings Call
PARSIPPANY Aug 10, 2018 (Thomson StreetEvents) — Edited Transcript of Interpace Diagnostics Group Inc earnings conference call or presentation Thursday, August 9, 2018 at 8:30:00pm GMT
TEXT…
View On WordPress
$IDXG 2018-08-09 : Transcripts- IDXG Edited Transcript of IDXG earnings conference call
$IDXG 2018-08-09 : Transcripts- IDXG Edited Transcript of IDXG earnings conference call
[s2If !current_user_can(access_s2member_level0)] Please login to read the transcript. [lwa] [/s2If][s2If current_user_can(access_s2member_level0)]”
Q2 2018 Interpace Diagnostics Group Inc Earnings Call
PARSIPPANY Aug 10, 2018 (Thomson StreetEvents) — Edited Transcript of Interpace Diagnostics Group Inc earnings conference call or presentation Thursday, August 9, 2018 at 8:30:00pm GMT
TEXT…
View On WordPress
$idxg
IDXG earnings Tuesday, upgraded PT by many – AC wainright is here
View On WordPress
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) Files An 8-K Entry into a Material Definitive Agreement
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) Files An 8-K Entry into a Material Definitive Agreement
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) Files An 8-K Entry into a Material Definitive Agreement Item 1.01Entry into a Material Definitive Agreement. Effective January 3, 2017, Interpace Diagnostics Group, Inc. (the Company) entered into an amended and restated placement agency agreement (the Amended Placement Agreement) with Maxim Group LLC (the Placement Agent) to which the Placement…
View On WordPress
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) Files An 8-K Other Events
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) Files An 8-K Other Events
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) Files An 8-K Other Events Item 8.01Other Events As previously disclosed in Amendment No. 1 to its Current Report on Form 8-K/A filed on January 5, 2017, Interpace Diagnostics Group, Inc. (the Company) announced a registered direct public offering of 630,000 shares of the Companys common stock, par value $0.01 per share (the Common Stock), at a price…
View On WordPress
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) Files An 8-K Other Events
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) Files An 8-K Other Events
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) Files An 8-K Other Events Item 8.01Other Events As previously disclosed in Amendment No. 1 to its Current Report on Form 8-K/A filed on January 5, 2017, Interpace Diagnostics Group, Inc. (the Company) announced a registered direct public offering of 630,000 shares of the Companys common stock, par value $0.01 per share (the Common Stock), at a price…
View On WordPress
